GobyMeds review

The headline figures are genuinely low — both molecules sit at the bottom of the published range on this site — and they are visible before any intake, which is more than a fair share of the field manages. What those figures describe is a three-month purchase. Both entry offers are starter bundles containing three months of medication, and no single-month price appears anywhere on the site, so a reader who wants to try one month and stop cannot establish what that would cost, or whether it is offered at all. That is not a hidden fee, but it does mean the cheap number carries a commitment the headline never mentions. Two smaller notes. No dose sits behind either figure, so the usual question of what happens as the dose climbs goes unanswered here as it does almost everywhere. And the NAD+ line is advertised as the most competitive price in telehealth — a comparative claim about an entire market with nothing on the page to support it. That is worth registering, because a seller willing to assert something that broad without evidence is telling you how to read its other claims.

Vs median

$76/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

GobyMeds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The headline figures are genuinely low — both molecules sit at the bottom of the published range on this site — and they are visible before any intake, which is more than a good share of the field manages. What the figures describe is a three-month purchase. Both entry offers are starter bundles containing three months of medication, and no single-month price appears anywhere, so a reader who wants to try one month and stop cannot find out what that costs or whether it is offered at all. That is not the same as a hidden fee, but it does mean the cheap number requires a commitment the headline does not mention. Two smaller things. No dose sits behind either figure, so the usual question of what happens as the dose climbs is unanswered. And the NAD+ line is advertised as the most competitive price in telehealth, a comparative claim about an entire market that nothing on the page substantiates — worth noticing, because a seller willing to assert that without evidence is telling you something about how to read its other claims.

The monthly figures describe three-month bundles; no single-month price is published.

• No dose is published behind either figure.
• Its NAD+ line claims the most competitive price in telehealth, which nothing substantiates.

GobyMeds is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• What the evidence actually shows
• The true annual cost of a plan
• What a flat price costs at a low dose